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Thesis Summary 
  Implantable biomaterials, which are recognized as foreign bodies to human body may lead to 
risks of complication such as inflammation by host response of the human body. Especially, 
blood-contacting implants potentially induce thrombus formation by the accumulation of blood cells 
due to insufficient compatibility of themselves for blood components. Therefore, the development of 
antithrombotic materials has been studied for several decades to suppress thrombotic 
complications after implantation. Amorphous carbon (a-C) coating which includes “diamond-like 
carbon (DLC)” has been reported and expected as a coating material for medical devices because of 
its biocompatible and hemocompatible properties. Since doping additive element into a-C films 
enhances various properties of them, many studies have reported biocompatibility of a-C films. 
Fluorine incorporated hydrogenated amorphous carbon (a-C:H:F) is one of the excellent 
antithrombotic and anti-inflammatory amorphous carbon coating and expected to be applied to 
medical devices. This work aimed to develop and apply well-biocompatible surface by using fluorine 
incorporated amorphous carbon coatings. 
  Chapter 1 is the introduction of this thesis: problems of vascular implants, coating technologies 
for blood-contacting devices, and the a-C film as an antithrombotic coating. At first, the stability 
and safety of a-C:H:F coating as biomaterial was reported in chapter 2. In the second part, a-C:H:F 
coating was applied to conventional medical polymers. In chapter 3, poor adhesive properties of 
a-C:H:F surface were focused and studied for an anti-sticking layer on medical devices. The 
adhesiveness of the a-C:H:F coated polymer to a therapeutic adhesive agent was evaluated. On the 
other hands, in chapter 4, a-C:H:F was used as an interlayer of medical fluoropolymer and the 
anti-bacterial amorphous carbon film and improved adhesive properties of them. Furthermore, in 
chapter 5, focused on the low hardness of antithrombotic a-C:H:F coatings, new deposition method 
of fluorine incorporated amorphous carbon are established as the third part of this thesis. By using 
filtered cathodic vacuum arc method which is used for synthesizing hard hydrogen-free amorphous 
carbon, hydrogen-free fluorine incorporated amorphous carbon (a-C:F) were developed and 
evaluated as hard and blood compatible coating. The last part of this research was the fundamental 
mechanism of platelet activation on the a-C:H:F film. I observed the internal granules of surface 
adherent platelet and adhesion interface with transmission electron microscopy in order to 
investigate antithrombogenicity of a-C:H:F film in chapter 6. 
Finally, chapter 7 summarizes this thesis and showed future prospect of antithrombotic 
amorphous carbon coating as conclusion part.   
